Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting.

Rosencher, Nadia; Samama, Charles M; Feuring, Martin; Brueckmann, Martina; Kleine, Eva; Clemens, Andreas; Frostick, Simon.

Afiliação

Rosencher N; Department of Anaesthesia and Intensive Care Medicine, Cochin University Hospital, Assistance-Publique - Hôpitaux de Paris; Université Paris Descartes, Paris, France.
Samama CM; Department of Anaesthesia and Intensive Care Medicine, Cochin University Hospital, Assistance-Publique - Hôpitaux de Paris; Université Paris Descartes, Paris, France.
Feuring M; Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany ; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Brueckmann M; Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany ; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Kleine E; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Clemens A; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Frostick S; Royal Liverpool University Hospital, Liverpool, L69 3GA UK.

Thromb J ; 14: 8, 2016.

Article em En | MEDLINE | ID: mdl-27042163